By Michael Susin Bivictrix Therapeutics said its leukemia treatment has been granted a patent by the U.S. Patent and Trademark Office. The cancer-therapies.
Bivictrix Therapeutics PLC on Wednesday said it has been granted a US patent for lead asset BVX001.
The Macclesfield, England-based biotechnology company focusing on cancer therapies said the.
The following stocks are the leading risers and fallers on AIM in London on Wednesday.
AIM - WINNERS
Jadestone Energy PLC, up 25% at 27.60 pence, 12-month range 21p-94.4p. The.